Reversal of vinblastine transport by chlorpromazine in membrane vesicles from multidrug-resistant human CCRF-CEM leukaemia cells

British Journal of Cancer

Volumn 78, Issue 3, 1998, Pages 321-327

  Syed, S K ^a   Christopherson, R I ^a   Roufogalis, B D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Chlorpromazine; Leukaemia; Multidrug resistance; P glycoprotein; Vinblastine

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHLORPROMAZINE; COLCHICINE; GLYCOPROTEIN P; PHENOXYBENZAMINE; VINBLASTINE;

ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; KINETICS; LEUKEMIA CELL; MEMBRANE VESICLE; PRIORITY JOURNAL;

EID: 0031815188     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.493     Document Type: Article

References (30)

1. Akiyama S-I, Cornwell MM, Kuwano M, Pastan I and Gottesman MM (1988) Most drugs that reverse multidrug resistance also inhibit photoaffinity labelling of P-glycoprotein by a vinblastine analog. Mol Pharmacol 33: 144-147
2. Arias I (1990) Multidrug resistance genes, P-glycoprotein and the liver. Hepatology 12: 159-165
3. Azzaria ME, Schurr E and Gros P (1989) Discrete mutations introduced in the predicted nucleotide-binding sites of the mdrl gene abolish its ability to confer multidrug resistance. Mol Cell Biol 9: 5289-5287
4. Beck WT and Qian X-D (1992) Photoaffinity substrates for P-glycoprotein. Biochem Pharmacol 43: 89-93
5. Ferry DR, Russell MA and Cullen MH (1992) P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is allosterically coupled to a vinca-alkaloid-selective binding site. Biochem Biophys Res Commun 188: 440-445
6. Fojo A, Akiyama SI, Gottesman MM and Pastan I (1985) Reduced drug accumulation in multiple drug-resistant human KB carcinoma cell lines. Cancer Res 45: 3002-3007
7. Ford JM, Prozialeck WC and Hait WN (1989) Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance. Mol Pharmacol 35: 105-115
8. Gottesman MM and Pastan I (1988) The multidrug transporter, a double-edged sword. J Biol Chem 263: 12163-12166
9. Hamada H and Tsuruo T (1988) Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance. 170- to 180- kilodalton membrane glycoprotein is an ATPase. J Biol Chem 263: 1454-1458
10. Higgins CF and Gottesman MM (1992) Is the multidrug transporter a flippase? Trends Biochem Sci 17: 18-21
11. Hofsli E and Nissen-Meyer J (1990) Reversal of multidrug resistance by lipophilic drugs. Cancer Res 50: 3997-4002
12. Horio M, Gottesman MM and Pastan I (1988) ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc Natl Acad Sci USA 88: 3580-3584
13. 3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells. Eur J Pharmacol 288: 105-114
14. McLaughlin S and Eisenberg M (1975) Antibiotics and membrane biology. Annu Rev Biophys Bioeng 4: 335-366
15. May GL, Wright LC, Dyne M, Mackinnon WB, Fox RM and Mountford CE (1988) Plasma membrane lipid composition of vinblastine sensitive and resistant human leukaemic lymphoblasts. Int J Cancer 42: 728-733
16. Miyamoto KI, Koga-Takeda K, Koga K, Ohshima T and Nomura M (1996) Saturable function of P-glycoprotein as a drug-efflux pump in multidrug-resistant tumour cells. J Pharm Pharmacol 48: 522-525
17. Monod J, Wyman J and Changeux JP (1965) On the nature of allosteric transitions: a plausible model. J Mol Biol 12: 88-95
18. Nooter K, Oostrum R, Jonker R, Van Dekken H, Stokdijk W and Van Den Engh G (1989) Effect of cyclosporin A on daunorubicin accumulation in multidrug resistant P388 leukaemia cells measured by real-time flow cytometry. Cancer Chemother Plarmacol 23: 296-300.
19. Pereira E, Borrel MN, Fiallo M and Garnier-Suillerot A (1994) Non-competitive inhibition of P-glycoprotein-associated efflux of THP-adriamycin by verapamil in living K562 leukemia cells. Biochim Biophys Acta 1225: 209-216
20. Rosenberg MF, Callaghan R, Ford RC, Higgens CF (1997) Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J Biol Chem 272: 10685-10694
21. Safa AR, Glover CJ, Meyers M, Biedler JL and Felsted RL (1986) Vinblastine photoaffinity labelling and a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells. J Biol Chem 261: 6137-6140
22. 3H]-chlorpromazine across rat small intestinal brush border membrane. J Pharm Pharmacol 41: 200-202
23. Sehested M, Skovsgaard P, Jensen PB, Demant EJ, Friche E and Bindslev N (1990) Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells. Br J Cancer 62: 37-41
24. Shibata H and Ghishan FK (1990) Intestinal calcium transport in spontaneously hypertensive rats (SHR) and their genetically matched WK4 rats. Proc Soc Exp Biol Med 194: 26-31
25. Spoelstra EC, Westerhoff HV, Dekker H, Lankelma J (1992) Kinetics or daunorubicin transport by P-glycoprotein of intact cancer cells. Eur J Biochem 207: 567-579
26. Stein WD (1997) Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol Rev 77: 545-590
27. Syed SK, Christopherson RI and Roufogalis BD (1993) Vinblastine transport by membrane vesicles from human multi-drug resistant CCRF-CEM leukacmia cells: inhibition by taxol and membrane permeabilising agents. Biochem Mol Biol Int 30: 743-753
28. Syed SK, Christopherson RI and Roufogalis BD (1996) Chlorpromazine transport in membrane vesicles from multidrug resistant CCRF-CEM cells. Biochem Mol Biol Int 39: 687-696
29. Tamai I and Safa AR (1991) Azidopine non-competitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells. J Biol Chem 266: 16796-16800
30. Tsuruo T, Lida H, Tsukagoshi S and Sakurai Y (1982) Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumour cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res 42: 4730-4733